Results 71 to 80 of about 63,206 (209)

Acute renal failure in an AIDS patient on tenofovir: a case report

Journal of Medical Case Reports, 2008
Introduction Tenofovir is a potent nucleotide analogue reverse-transcriptase inhibitor used with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV) infection.
Kapitsinou Pinelopi P, Ansari Naheed
doaj   +1 more source

Exploring the impact of Cabotegravir‐Rilpivirine long‐acting on weight gain, body composition and quality of life in adults living with HIV

HIV Medicine, EarlyView.
Abstract Introduction Long‐acting injectable antiretroviral therapy (ART) with Cabotegravir (CAB) and Rilpivirine (RPV) offers an alternative to daily oral regimens, improving adherence and patient satisfaction. However, its impact on body composition and metabolism remains underexplored.
Andrea De Vito, Andrea Marongiu, Antonella Cano, Mariangela Puci, Agnese Colpani, Susanna Maria Nuvoli, Maria Grazia Catte, Giulia Moi, Maria Antonietta Deledda, Sergio Uzzau, Giovanni Sotgiu, Franca Deriu, Angela Spanu, Giordano Madeddu   +13 more
wiley   +1 more source

Virological outcomes with Bictegravir/Emtricitabine/Tenofovir alafenamide (B/F/TAF) in people previously treated with darunavir‐based antiretroviral therapy

HIV Medicine, EarlyView.
Abstract Background Darunavir‐based antiretroviral therapy (ART) is commonly used in people with HIV who experience adherence challenges and/or have complex resistance patterns. Changes in ART commissioning have led to an increased use of Bictegravir/Emtricitabine/Tenofovir alafenamide (B/F/TAF) in these populations despite limited real‐world outcome ...
Rhianna Sheridan, Yasmin Osei‐Kuffour Ekert, Lucy Campbell, Mark Zuckerman, Sally Hawkins, Kate Childs, Frank A. Post   +6 more
wiley   +1 more source

Early Onset of Tenofovir-Induced Renal Failure: Case Report and Review of the Literature

The Scientific World Journal, 2007
Tenofovir is an acyclic nucleotide analogue reverse transcriptase inhibitor that is commonly prescribed as part of a highly active antiretroviral therapy (HAART) regimen in HIV-infected patients.
Shilpa M. Patel, Teresa R. Zembower, Frank Palella, Yashpal S. Kanwar, Shubhada N. Ahya   +4 more
doaj   +1 more source

Effect of tenofovir Administration And Withdrawl On The Kidney Tissues Of Adult Male Albino Rats And The Protective Role Of Vitamin E

SVU-International Journal of Veterinary Sciences, 2019
Tenofovir disoproxil fumarate is one of antiretroviral drugs used to treat chronic hepatitis B and HIV. In recent studies many Tenofovir problems were recorded; acute kidney injury (AKI), chronic kidney diseases (CKD) and Fanconi syndrome. Vitamin E is
Rasha M. Abd El-Fattah, Dorreia M. Zaghloul, Eman A. Abd Elrahim, Salwa M. Ouies   +3 more
doaj   +1 more source

Impact of chronic hepatitis B virus infection on bone mineral density

Medical Journal of Babylon, 2020
Background: Chronic hepatitis B virus (HBV) infection is a common health problem that has a worldwide distribution. Apart from the direct effect of the virus on the liver, there are many extrahepatic manifestations among which the probable effect on bone
Istabraq A Al-Husseiny, Maysaa K Al-Malkey, Maitham A Al-Sammak, Faheema J Abo-Alhur   +3 more
doaj   +1 more source

Development of Mucoadhesive Gel Microbicide to Target Mucosal HIV Reservoirs [PDF]

, 2014
The wide use of microbicide is mainly depends on its effectiveness, less frequent application, ready availability and most importantly cost. The aim of this work was to develop affordable microbicide mucoadhesive gel formulation of synthetic anti HIV ...
Shegokar, Ranjita, Singh, Kamalinder K
core   +1 more source

Pharmacovigilance study of INSTIs associated with weight gain and glucose/lipid metabolism adverse events based on the FDA adverse event reporting system

HIV Medicine, EarlyView.
Abstract Objective Integrase strand transfer inhibitors (INSTIs) are widely used in antiretroviral therapy (ART) for people with HIV due to their efficacy and tolerability. However, concerns about weight gain and metabolic disturbances have emerged.
Leidan Zhang, Ling Chen, Jia Tang, Xiaosheng Liu, Liyuan Zheng, Fada Wang, Xin Huang, Wei Cao, Taisheng Li   +8 more
wiley   +1 more source

[Tenofovir and entecavir for chronic hepatitis B infection treatment: a single-center experience]

Clinical Management Issues, 2015
BACKGROUND AND AIM: The current treatment of chronic hepatitis B infection (CHBV) has achieved several step-ups thanks to the introduction of the new-generation nucleos(t)ide analogs.
Fabio Tarsetti, Giuseppe Tarantino, Piergiorgio Mosca, Emidio Scarpellini, Giammarco Fava   +4 more
doaj   +1 more source

Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa? [PDF]

, 2017
This version is the Accepted Manuscript and is published in final edited form as: AIDS. 2017 January 02; 31(1): 147–157. doi:10.1097/QAD.0000000000001307OBJECTIVE: We assessed the relationship between phasing out stavudine in first-line antiretroviral ...
Bor, Jacob, Boulle, A., Brennan, Alana T., Davies, Mary-Ann, de Rekeneire, N., Fatii, G., Fox, M.P., Leroy, V., Prozesky, H., Sikazwe, I., Stinson, K., Tanser, F., Wandelere, G., Wood, R., Wool-Kaloustian, K., Yuannoutsos, C.   +15 more
core   +2 more sources